FDA: Auvi-Q epinephrine injection recalled

Posted in Latest News on October 30, 2015.

Under a voluntary recall, Sanofi US has recalled all Auvi-Q products on the market in both 0.15 mg and 0.3 mg because of suspected device malfunctions, the FDA announced this week. The product is available to hospitals, retailers and customers.

According to the FDA announcement, the product can deliver the wrong dosage. A patient experiencing allergic reaction could die if the proper dosage is not used.



More Latest News

New Legislation Impacting Your Profession
June 29, 2021

Click here to view a full list of bill summaries from the 2021 Florida Legislative Session that may impact your profession. Continue reading


Third Quarter Performance Report
June 9, 2021

Released for the
2020-21 Fiscal Year Continue reading